SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

References

• Marklund, SL, Holme, E, Hellner, L. Superoxide dismutase in extracellular fluids. Clin Chim Acta 1982; 126:41–51.
   PubMed Web of Science ®Google Scholar
• Karlsson, K, Marklund, SL. Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells. Lab Invest 1989; 60:659–666.
   PubMedGoogle Scholar
• Stralin, P, Karlsson, K, Johansson, BO, Marklund, SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995; 15:2032–2036.
   PubMed Web of Science ®Google Scholar
• Karlsson, K, Marklund, SL. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J 1987; 242:55–59.
   PubMed Web of Science ®Google Scholar
• Adachi, T, Yamada, H, Futenma, A, Kato, K, Hirano, K. Heparin-induced release of extracellular-superoxide dismutase form (V) to plasma. J Biochem 1995; 117:586–590.
   PubMedGoogle Scholar
• Landmesser, U, Merten, R, Spiekermann, S, Buttner, K, Drexler, H, Hornig, B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000; 101:2264–2270.
   PubMed Web of Science ®Google Scholar
• Adachi, T, Yamada, H, Yamada, Y, Morihara, N, Yamazaki, N, Murakami, T, Futenma, A, Kato, K, Hirano, K. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem J 1996; 313:235–239.
   PubMedGoogle Scholar
• Adachi, T, Wang, J, Wang, XL. Age-related change of plasma extracellular-superoxide dismutase. Clin Chim Acta 2000; 290:169–178.
   PubMedGoogle Scholar
• Frederiksen, J, Juul, K, Grande, P, Jensen, GB, Schroeder, TV, Tybjaerg-Hansen, A, Nordestgaard, BG. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. Blood 2004; 104:3046–3051.
   PubMed Web of Science ®Google Scholar
• Fukai, T, Folz, RJ, Landmesser, U, Harrison, DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 2002; 55:239–249.
   PubMed Web of Science ®Google Scholar
• Lund, DD, Chu, Y, Brooks, RM, Faraci, FM, Heistad, DD. Effects of a common human gene variant of extracellular superoxide dismutase on endothelial function after endotoxin in mice. J Physiol 2007; 584:583–590.
   PubMedGoogle Scholar
• Fattman, CL, Schaefer, LM, Oury, TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 2003; 35:236–256.
   PubMed Web of Science ®Google Scholar
• Marklund, SL, Nilsson, P, Israelsson, K, Schampi, I, Peltonen, M, Asplund, K. Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med 1997; 242:5–14.
   PubMed Web of Science ®Google Scholar
• Horiuchi, M, Tsutsui, M, Tasaki, H, Morishita, T, Suda, O, Nakata, S, Nihei, S, Miyamoto, M, Kouzuma, R, Okazaki, M, Yanagihara, N, Adachi, T, Nakashima, Y. Upregulation of vascular extracellular superoxide dismutase in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 2004; 24:106–111.
   PubMedGoogle Scholar
• Kimura, F, Hasegawa, G, Obayashi, H, Adachi, T, Hara, H, Ohta, M, Fukui, M, Kitagawa, Y, Park, H, Nakamura, N, Nakano, K, Yoshikawa, T. Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. Diabetes Care 2003; 26:1246–1250.
   PubMed Web of Science ®Google Scholar
• Winkelmann, BR, März, W, Boehm, BO, Zotz, R, Hager, J, Hellstern, P, Senges, J. Rationale and design of the LURIC study–a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001; 2:S1–S73.
   PubMed Web of Science ®Google Scholar
• Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31(Suppl 1):S55–S60.
   PubMed Web of Science ®Google Scholar
• Friesinger, GC, Page, EE, Ross, RS. Prognostic significance of coronary arteriography. Trans Assoc Am Physicians 1970:78–92.
   PubMedGoogle Scholar
• Aebischer, CP, Schierle, J, Schuep, W. Simultaneous determination of retinol, tocopherols, carotene, lycopene, and xanthophylls in plasma by means of reversed-phase high-performance liquid chromatography. Methods Enzymol 1994; 299:348–362.
   Google Scholar
• Sandstrom, J, Nilsson, P, Karlsson, K, Marklund, SL. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem 1995; 269:19163–19166.
   Google Scholar
• Yamada, H, Yamada, Y, Adachi, T, Goto, H, Ogasawara, N, Futenma, A, Kitano, M, Hirano, K, Kato, K. Molecular analysis of extracellular-superoxide dismutase gene associated with high level in serum. Jpn J Hum Genet 2004; 40:177–184.
   Google Scholar
• Juul, K, Tybjaerg-Hansen, A, Marklund, S, Heegaard, NH, Steffensen, R, Sillesen, H, Jensen, G, Nordestgaard, BG. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. Circulation 1998; 109:59–65.
   Google Scholar
• Antonarakis, SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1992; 11:1–3.
   Google Scholar
• Adachi, T, Ohta, H, Yamada, H, Futenma, A, Kato, K, Hirano, K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta 1998; 212:89–102.
   Google Scholar
• Wang XL, Adachi T, Sim AS, Wilcken DE. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol 1915; 18: 1921
   Google Scholar
• Petersen, SV, Olsen, DA, Kenney, JM, Oury, TD, Valnickova, Z, Thogersen, IB, Crapo, JD, Enghild, JJ. The high concentration of Arg213→Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities. Biochem J 2005; 385:427–432.
   PubMed Web of Science ®Google Scholar
• Chu, Y, Alwahdani, A, Iida, S, Lund, DD, Faraci, FM, Heistad, DD. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation 2005; 112:1047–1053.
   PubMed Web of Science ®Google Scholar
• Yamada, H, Yamada, Y, Adachi, T, Fukatsu, A, Sakuma, M, Futenma, A, Kakumu, S. Protective role of extracellular superoxide dismutase in hemodialysis patients. Nephron 2000; 84:218–223.
   PubMedGoogle Scholar
• Esterbauer, H, Puhl, H, Dieber-Rotheneder, M, Waeg, G, Rabl, H. Effect of antioxidants on oxidative modification of LDL. Ann Med 1991; 23:573–581.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Waeg G, Puhl H, Dieber-Rotheneder M, Tatzber F. Inhibition of LDL oxidation by antioxidants. Exs 1992; 62: 145–157
   PubMedGoogle Scholar
• Thomas SR, Stocker R. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis. Free Radic Biol Med 2000; 28: 1795
   PubMed Web of Science ®Google Scholar
• Traber, MG, Frei, B, Beckman, JS. Vitamin E revisited: do new data validate benefits for chronic disease prevention?. Curr Opin Lipidol 2008; 19:30–38.
   PubMed Web of Science ®Google Scholar
• Keaney, JF, Jr., Guo, Y, Cunningham, D, Shwaery, GT, Xu, A, Vita, JA. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 1996; 98:386–394.
   PubMedGoogle Scholar
• Li D, Devaraj S, Fuller C, Bucala R, Jialal I. Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. J Lipid Res 1996; 37: 1986
   Google Scholar
• Singh, U, Devaraj, S, Jialal, I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005; 25:151–174.
   PubMed Web of Science ®Google Scholar
• Devaraj, S, Tang, R, Adams-Huet, B, Harris, A, Seenivasan, T, de Lemos, JA, Jialal, I. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007; 86:1392–1398.
   PubMed Web of Science ®Google Scholar
• Higashi, O, Kikuchi, Y. Effects of vitamin E on the aggregation and the lipid peroxidation of platelets exposed to hydrogen peroxide. Tohoku J Exp Med 1974; 112:271–278.
   PubMedGoogle Scholar
• Steiner, M, Anastasi, J. Vitamin E. An inhibitor of the platelet release reaction. J Clin Invest 1976; 57:732–737.
   PubMed Web of Science ®Google Scholar
• Freedman, JE, Farhat, JH, Loscalzo, J, Keaney, JF, Jr. alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996; 94:2434–2440.
   PubMed Web of Science ®Google Scholar
• Devaraj, S, Li, D, Jialal, I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest 1996; 98:756–763.
   PubMed Web of Science ®Google Scholar
• Thomson, MJ, Puntmann, V, Kaski, JC. Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment?. Cardiovasc Drugs Ther 2007; 21:195–210.
   PubMed Web of Science ®Google Scholar
• Jha, P, Flather, M, Lonn, E, Farkouh, M, Yusuf, S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123:860–872.
   PubMed Web of Science ®Google Scholar
• Pryor, WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med. 2000; 28:141–164.
   Google Scholar
• Hirschhorn, JN, Lohmueller, K, Byrne, E, Hirschhorn, K. A comprehensive review of genetic association studies. Genet Med 2002; 4:45–61.
   PubMed Web of Science ®Google Scholar
• Campbell, H, Rudan, I. Interpretation of genetic association studies in complex disease. Pharmacogenomics J 2002; 2:349–360.
   PubMedGoogle Scholar
• Tabor, HK, Risch, NJ, Myers, RM. Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002 ;3:391–397.
   PubMed Web of Science ®Google Scholar